Biotech & AI drug discoveryNature Medicine

Next-generation KRAS G12C inhibitor improves survival in lung cancer

A next-generation KRAS G12C inhibitor has been reported to improve survival in lung cancer, according to Nature Medicine.

AI summary · generated only from source feed metadata; consult original

Source published2026-11-10T00:00:00+00:00

Published here2026-11-11T01:33:50+00:00

Original source

Nature Medicine

Media report · consult original reporting

Read the original ↗https://www.nature.com/articles/d41591-026-00057-9

Original headline

Next-generation KRAS G12C inhibitor improves survival in lung cancer

AI bilingual edit · consult original

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.